publication venue for
- Author Correction: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases. 2024
- A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease.. 11. 2025
- Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson's disease.. 10. 2024
- Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases.. 9. 2023
- Alpha synuclein modulates mitochondrial Ca2+ uptake from ER during cell stimulation and under stress conditions.. 9. 2023
- Corneal confocal microscopy differentiates patients with Parkinson's disease with and without autonomic involvement.. 8. 2022
- Comprehensive subtyping of Parkinson's disease patients with similarity fusion: a case study with BioFIND data.. 7. 2021
- Corneal nerve fiber loss relates to cognitive impairment in patients with Parkinson's disease.. 7. 2021
- Regulation of exocytosis and mitochondrial relocalization by Alpha-synuclein in a mammalian cell model.. 5. 2019
- Remembering John Q Trojanowski, in his own words: A life dedicated to discovering building blocks and using them to build bridges of knowledge, collaboration, and discovery.. 8. 2022
- Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies. 2022
- Mining genetic and transcriptomic data using machine learning approaches in Parkinson's disease. 2020
- COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside. 2020